NasdaqGS - Delayed Quote • USD
AVROBIO, Inc. (AVRO)
At close: April 23 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 2 |
| Avg. Estimate | -0.36 | -0.08 | -0.48 | -0.33 |
| Low Estimate | -0.36 | -0.08 | -0.48 | -0.5 |
| High Estimate | -0.36 | -0.08 | -0.48 | -0.17 |
| Year Ago EPS | -0.57 | 1.52 | 0.31 | -0.48 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.54 | -0.07 | -0.28 | -0.34 |
| EPS Actual | -0.57 | 1.52 | -0.44 | -0.2 |
| Difference | -0.03 | 1.59 | -0.16 | 0.14 |
| Surprise % | -5.60% | 2,271.40% | -57.10% | 41.20% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.36 | -0.08 | -0.48 | -0.33 |
| 7 Days Ago | -0.36 | -0.08 | -0.48 | -0.33 |
| 30 Days Ago | -0.36 | -0.08 | -0.65 | -0.44 |
| 60 Days Ago | -0.16 | -0.16 | -0.65 | -0.41 |
| 90 Days Ago | -0.16 | -0.16 | -0.81 | -0.65 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | AVRO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 36.80% | -- | -- | 0.40% |
| Next Qtr. | -105.30% | -- | -- | 9.90% |
| Current Year | -254.80% | -- | -- | 4.30% |
| Next Year | 31.20% | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Downgrade | Mizuho: Buy to Neutral | 12/18/2023 |
| Maintains | Wells Fargo: Overweight to Overweight | 7/13/2023 |
| Downgrade | Wedbush: Outperform to Neutral | 7/12/2023 |
| Maintains | Mizuho: Buy | 3/24/2023 |
| Reiterates | Needham: Buy | 3/24/2023 |
| Upgrade | BTIG: Neutral to Buy | 12/8/2022 |
Related Tickers
AUTL Autolus Therapeutics plc
4.4800
-1.75%
TSBX Turnstone Biologics Corp.
3.0600
+4.79%
CTMX CytomX Therapeutics, Inc.
1.6800
+0.60%
REPL Replimune Group, Inc.
6.42
0.00%
BCEL Atreca, Inc.
0.0800
-5.88%
GBIO Generation Bio Co.
3.2600
+16.01%
CMPX Compass Therapeutics, Inc.
1.5200
+2.01%
STRO Sutro Biopharma, Inc.
3.7200
-1.33%
BOLT Bolt Biotherapeutics, Inc.
1.1100
0.00%
RPHM Reneo Pharmaceuticals, Inc.
1.6750
-0.89%